Strength training was not associated with an increased risk of sustained ventricular arrhythmia among people living with or at genetic risk for arrhythmogenic cardiomyopathy (ACM) ...

FDA expanded finerenone use to CKD with type 1 diabetes to reduce UACR, positioning it as the only MRA indicated across CKD associated with type 1 and type 2 diabetes. FINE-ONE (n=242) showed ...

Most people with narcolepsy and idiopathic hypersomnia (IH) stay employed, but many struggle at work and receive little workplace support, often without disclosing their condition to employers, ...

Karolinska Institutet reports ROR1 inhibitor KAN571C wipes out double‑resistant MCL after ibrutinib/venetoclax, spotlighting ...

Nicola A. Hanania, MD, MS, is an associate professor of medicine in the section of pulmonary and critical care medicine and director of the American Lung Association Airways Clinical Research Center ...

Community oncology leaders urge 340B overhaul so drug discounts follow vulnerable cancer patients, with audits, transparency, and tighter contract-pharmacy rules. This commentary will be featured on ...

Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in. Obesity is diagnosed during hundreds of thousands, if not ...

A population-based cohort (1996–2021) of 2.94 million individuals assigned female at birth found endometriosis conferred ...

Community oncology leaders urge 340B overhaul so drug discounts follow vulnerable cancer patients, with audits, transparency, ...

ASCOLT finds no overall adjuvant aspirin benefit in colorectal cancer, but meta-analysis links improved disease-free survival ...

HFpEF/HFmrEF represent roughly 60% to 75% of US heart failure, and registries report >70% HFpEF, yet morbidity and mortality appear similar across ejection fraction categories.

Real-world COPD data from ERS 2026 support RSV vaccination, but Jorgen Vestbo, MD, says cost remains the biggest barrier to ...